--- title: CDMOs offering ADC (Antibody-Drug Conjugate) Manufacturing with Biologics (Monoclonal Antibodies) path: /explore/adc-manufacturing/biologics-monoclonal-antibodies companies_count: 21 --- # CDMOs offering ADC (Antibody-Drug Conjugate) Manufacturing with Biologics (Monoclonal Antibodies) 21 published CDMOs match ADC (Antibody-Drug Conjugate) Manufacturing and Biologics (Monoclonal Antibodies). Locations in this set include United States, China, Germany, United Kingdom, Italy, and Japan. Capabilities that show up most often in this set: CMC Analytical Development, Monoclonal Antibody (mAb) Manufacturing, Process Development, Recombinant Protein Manufacturing, and Biologics Development & Manufacturing. ## Matching companies - [AGC Biologics](/companies/agcbio) - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. - [AbbVie Contract Manufacturing](/companies/abbviecontractmfg) - Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe. - [Abzena](/companies/abzena) - Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale. - [Altruist Biologics](/companies/altruist-biologics) - Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors. - [Amerigo Scientific](/companies/amerigo-scientific) - Amerigo Scientific supplies specialized research reagents and GMP-grade materials for ADC, mRNA, AAV, and cell therapy development, including PROTAC linkers, ADC payloads and linkers, mRNA synthesis enzymes, and cell culture tools. - [AsymBio](/companies/asymbio) - AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production. - [Avid Bioservices](/companies/avidbio) - Avid Bioservices is a U.S.-based mammalian cell culture CDMO providing integrated process development, analytical development, and CGMP biologics manufacturing from DNA to IND to commercial supply, with 30+ years of expertise and FDA-inspected facilities in California. - [BSP Pharmaceuticals](/companies/bsppharmaceuticals) - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply. - [Celonic](/companies/celonic) - Swiss-based pure-play biologics CDMO specializing in next-generation bioprocessing technologies including process intensification and full perfusion to reduce cost of goods for biotech and biosimilar clients. - [Icosagen](/companies/icosagen) - Icosagen is an integrated CRDMO (Contract Research, Development & Manufacturing Organization) specializing in antibody discovery, protein production, cell line development, and GMP manufacturing for biologics programs from discovery through commercial scale. - [Pfizer CentreOne](/companies/pfizercentreone) - Award-winning CDMO specializing in commercial manufacturing of oral solids, sterile injectables, and biologic drug products with Pfizer's technical expertise and global network. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Piramal Pharma Solutions](/companies/piramalpharmasolutions) - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management. - [STC Biologics](/companies/stcbiologics) - Boutique biologics CDMO with a Speed-to-Clinic platform spanning royalty-free cell line development through cGMP drug substance, in as little as 12 months. Runs a single-use mammalian GMP suite in Newton, MA for antibody, bispecific, and ADC programs. - [Samsung Biologics](/companies/samsungbiologics) - Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services. - [Simtra BioPharma Solutions](/companies/simtra-biopharma-solutions) - Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products. - [Symbiosis Pharmaceutical Services](/companies/symbiosis-pharma) - UK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S. - [Wheeler Bio](/companies/wheeler-bio) - Oklahoma-based CDMO specializing in antibody-based therapeutics from cell line development through cGMP manufacturing. Offers ModularCMC platform with phase-appropriate work packages and high-touch project management. - [WuXi Biologics](/companies/wuxibiologics) - Global biologic CDMO offering end-to-end solutions from discovery to commercialization.